[Discussion] the compounding gap was a symptom, not a solution
the compounding gap was a symptom, not a solution. It is the sort of thing everyone half-believes and nobody writes down. Asked which facility and got a name straight away. Looked it up, found the registration, felt considerably better about the whole thing. The intake asked me three questions and none of them were…
Push back: "compounded is fine because a pharmacy made it" skips every question this board exists to ask.
a 503B has to register and report, so there is a paper trail to ask for
Switched between two compounded preparations and the concentration on the label was different. Redid the arithmetic on paper before drawing anything.
Asked for potency testing on the finished preparation. They had it. I had assumed they would not.
Paid noticeably more at one clinic than another for what turned out to be the same facility behind both.
the pharmacy and the prescriber are two separate questions
the shortage list is the whole legal hinge and people skip it
Same view. If the intake asked you nothing, the intake was a formality and you should factor that in.
Who is the prescriber, and are they the same organisation as the pharmacy?